DUAL SPECIFICITY PROTEIN PHOSPHATASES: Therapeutic Targets for Cancer and Alzheimer's Disease
- 22 September 2005
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 45 (1) , 725-750
- https://doi.org/10.1146/annurev.pharmtox.45.120403.100040
Abstract
▪ Abstract The complete sequencing of the human genome is generating many novel targets for drug discovery. Understanding the pathophysiological roles of these putative targets and assessing their suitability for therapeutic intervention has become the major hurdle for drug discovery efforts. The dual-specificity phosphatases (DSPases), which dephosphorylate serine, threonine, and tyrosine residues in the same protein substrate, have important roles in multiple signaling pathways and appear to be deregulated in cancer and Alzheimer's disease. We examine the potential of DSPases as new molecular therapeutic targets for the treatment of human disease.Keywords
This publication has 137 references indexed in Scilit:
- Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysisOncogene, 2004
- Cdc25b phosphatase is required for resumption of meiosis during oocyte maturationNature Genetics, 2002
- p38 and Chk1 kinases: different conductors for the G2/M checkpoint symphonyCurrent Opinion in Genetics & Development, 2002
- A detailed transcriptional map of the chromosome 12p12 tumour suppressor locusEuropean Journal of Human Genetics, 2002
- Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replicationNature, 2001
- Molecular Genetic Analysis of Malignant Ovarian Germ Cell TumorsGynecologic Oncology, 2000
- Cell cycle-related protein expression in vascular dementia and Alzheimer's diseaseNeuroscience Letters, 1999
- Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer diseaseMedical Hypotheses, 1999
- Increased MAPK Activity and MKP-1 Overexpression in Human Gastric AdenocarcinomaBiochemical and Biophysical Research Communications, 1998
- The cell cycle regulator, human p50weel, is a tyrosine kinase and not a serine/tyrosine kinaseBiochemical and Biophysical Research Communications, 1992